NCT05902871View on ClinicalTrials.gov

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

NARecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

March 31, 2027

Conditions
Primary Open Angle GlaucomaOcular HypertensionNormal Tension Glaucoma
Interventions
DEVICE

External Automatic Glaucoma Laser

Trans-limbal, direct selective laser trabeculoplasty (DSLT) instrument that directs laser energy through the sclera around the limbus overlying the trabecular meshwork and treats 360 degrees of the angle is treated simultaneously

PROCEDURE

Direct Selective Laser Trabeculoplasty

Surgical procedure that utilizes a laser to improve fluid drainage in the eye and reduce intraocular pressure

Trial Locations (2)

Unknown

RECRUITING

C-Mer Eye Clinic, Hong Kong

RECRUITING

SERI, Singapore

Sponsors

Lead Sponsor

BelkinVision
All Listed Sponsors
lead

BelkinVision

INDUSTRY

NCT05902871 - Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population | Biotech Hunter | Biotech Hunter